Ponteland (GB)
{name}
{subtitle}
A Study to Learn How Safe the Study Drug BAY 2416964 (AhR Inhibitor) in Combination With the Treatment Pembrolizumab is, How This Combination Affects the Body, the Maximum Amount That Can be Given, How it Moves Into, Through and Out of the Body and Its Action Against Advanced Solid Cancers in Adults
city
~10 mi. (Newcastle upon Tyne, United Kingdom, +11 more cities)
facility
Freeman Hospital
condition
Malignant Solid Tumor
drug
BAY2416964, +1 more drug
drug type
immunotherapy
Study to Test How Well Patients With Advanced Solid Tumors Respond to Treatment With the Elimusertib in Combination With Pembrolizumab, to Find the Optimal Dose for Patients, How the Drug is Tolerated and the Way the Body Absorbs, Distributes and Discharges the Drug
city
~10 mi. (Newcastle upon Tyne, United Kingdom, +15 more cities)
facility
Freeman Hospital
biomarker
ARID1A Loss, +125 more biomarkers
condition
Adenocarcinoma of the Gastroesophageal Junction, +7 more conditions
drug
elimusertib, +1 more drug
drug type
immunotherapy, +1 more type
Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Cisplatin-ineligible Participants With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)
city
~52 mi. (Middlesbrough, United Kingdom, +163 more cities)
facility
The James Cook University Hospital ( Site 0730)
condition
Bladder Urothelial Carcinoma
drug
cystectomy, +2 more drugs
drug type
chemotherapy, +3 more types
A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)
city
~52 mi. (Middlesbrough, United Kingdom, +126 more cities)
facility
Local Institution
condition
Non-Small Cell Lung Carcinoma
drug
nivolumab, +2 more drugs
drug type
chemotherapy, +1 more type